Ischemic hepatitis: clinical presentation and pathogenesis

2000/08/01 by Reginald K Seeto, Reginald K. Seeto, Ben Fenn +2 · 28 citations
Medicine · Pharmacology, Toxicology and Pharmaceutics · #Liver Disease and Transplantation #Abdominal vascular conditions and treatments #Drug-Induced Hepatotoxicity and Protection

paper · doi:10.1016/s0002-9343(00)00461-7

Cited by

• Hypoxic hepatitis – epidemiology, pathophysiology and clinical management
• Liver enzyme alteration: a guide for clinicians
• Venous congestion from a vascular waterfall perspective: reframing congestion as a dynamic Starling resistor phenomenon
• Liver dysfunction after lung recruitment manoeuvres during pressure-controlled ventilation in experimental acute respiratory distress. [europepmc]
• Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. [europepmc]
• When the heart kills the liver: acute liver failure in congestive heart failure. [europepmc]
• Protective effect of L-carnitine and coenzyme Q10 on CCl₄-induced liver injury in rats. [europepmc]
• Systemic causes of cholestasis. [europepmc]
• Hypoxic Hepatitis: A Review and Clinical Update. [europepmc]
• Rare cause of acute hepatitis: a common energy drink. [europepmc]
• Increased Costs Associated with Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Bacteria Are Due Primarily to Patients with Hospital-Acquired Infections. [europepmc]
• Elevated Liver Enzymes in Asymptomatic Patients - What Should I Do? [europepmc]
• Serum concentrations of asymmetric and symmetric dimethylarginine are associated with mortality in acute heart failure patients. [europepmc]
• Acute Heart Failure developed as worsening of Chronic Heart Failure is associated with increased mortality compared to de novo cases. [europepmc]
• Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension. [europepmc]
• Maternal Venous Hemodynamic Dysfunction in Proteinuric Gestational Hypertension: Evidence and Implications. [europepmc]
• Serum Concentrations of Citrate, Tyrosine, 2- and 3- Hydroxybutyrate are Associated with Increased 3-Month Mortality in Acute Heart Failure Patients. [europepmc]
• Relationship between Heart Disease and Liver Disease: A Two-Way Street. [europepmc]
• SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. [europepmc]
• Newly Named Klebsiella aerogenes (formerly Enterobacter aerogenes) Is Associated with Poor Clinical Outcomes Relative to Other Enterobacter Species in Patients with Bloodstream Infection. [europepmc]
• Randomized Clinical Trial: Bergamot Citrus and Wild Cardoon Reduce Liver Steatosis and Body Weight in Non-diabetic Individuals Aged Over 50 Years. [europepmc]
• Congestive Hepatopathy. [europepmc]
• Hepatic Injury in Neonates with Perinatal Asphyxia. [europepmc]
• Infection of Human Cells by SARS-CoV-2 and Molecular Overview of Gastrointestinal, Neurological, and Hepatic Problems in COVID-19 Patients. [europepmc]
• Inflammatory response to the ischaemia-reperfusion insult in the liver after major tissue trauma. [europepmc]
• COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management. [europepmc]
• Prediction of 30-day mortality in heart failure patients with hypoxic hepatitis: Development and external validation of an interpretable machine learning model. [europepmc]
• Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines. [europepmc]